Fresenius: 43 or 30 euros? Curriculum and Ratings of the Analysts after Q2-Zahlen auf einen Blick – Aktiennews (aktiencheck.de)

Bad Marienberg (www.aktiencheck.de) – Welche Kursziele und Ratings trauen de Analysten der führenden Banken und Research-Häuser der Aktie des Medizinkonzerns Fresenius SE & Co. KGaA (ISIN: DE0005785604, WKN: 578560, Ticker-Symbol: FRE, NASDAQ OTC Symbol: FSNUF) after Bekanntgabe der Quartalszahlen zu? 43.00 or 30.00 Euro? We have the active Kursziele and Ratings van Fresenius-Aktie op een Blick-zusammenstellt.

The Fresenius SE & Co. KGaA is 31 years old. July will be released until 2. Quarter 2024.

The analysis of the analysis of the Fresenius stock had begun, Billigt zB Analyst Christian Ehmann of Analysehaus Warburg Research the title of the highest price of 43 euros. The purchase can take place on the purchase of a purchase. The entries fell in Bad Homburgern in a powerful way, when Ehmann appeared on August 1, responded to the written quartz messages.

I am skeptical about the analysts of the American investment bank Goldman Sachs: the American analyst Richard Felton has listed the shares of Fresenius at a “neutral” price with a price of 30 euros. The Medizinkonzern has a more robust number of quarters that Felton has proposed at the age of 31. Juli has written the first reaction.

Was he the Action Analyst of the advanced Banks and Research Houses for Fresenius-Aktie?

The current ratings and analyses of the Fresenius-Aktie stock analysts at a glance:

Cursor soul Fresenius Action (EUR)	Judgement Fresenius Action	Company	Action Analyst	Date
43.00	Buy	Warburg research	Christian Ehmann	01.08.2024
43.00	Buy	Berenbergbank	Victoria Lambert	31.07.2024
42.00	Buy	Deutsche Bank	Falko Friedrichs	31.07.2024
40.00	Overweight	Morgan Stanley	–	16.08.2024
40.00	Buy	Jefferies	James Vane-Tempest	08.08.2024
37.60	Neutral	JP Morgan	David Adlington	31.07.2024
36.50	Overweight	Barclays	Hassan Al-Wakeel	01.08.2024
30.00	Neutral	Goldman Sachs	Richard Felton	31.07.2024

Börsenplätze Fresenius-Action:

Tradegate-Aktienkurs Fresenius-Action:
EUR 32.72 -0.34% (26.08.2024, 22:02)

XETRA-Aktienkurs Fresenius-Action:
32.85 EUR 0.00% (26.08.2024, 17:35)

ISIN Fresenius-Action:
DE0005785604

WKN Fresenius Promotion:
578560

Fresenius-Aktie ticker symbol:
FREE

NASDAQ OTC symbol Fresenius-Aktie:
FSNUF

Kurzprofil Fresenius SE & Co. KGaA:

Die Fresenius SE & Co. KGaA (ISIN: DE0005785604, WKN: 578560, Ticker-Symbol: FRE, NASDAQ OTC-Symbol: FSNUF), 1912 from Frankfurter Apotheker Dr. Eduard Fresenius is gründet, ist een weltweit tätiger Gesundheitskonzern mit Hauptsitz in Bad Homburg vd Höhe, Germany. Fresenius offers opportunities for the social reforms that will emerge during a future and alternative population and the subsequent transition to better health and health care. Zum Konzern heard the operative Unternehmensbereiche Fresenius Kabi (hochkomplexe Biopharmazeutika, Klinische Ernährung, Medizintechnik und Generic Intravenous Verabreichte Arzneimittel) and Fresenius Helios (private Krankenhausbetreiber) die de Unternehmensbeteiligung Fresenius Medical Care. (26.08.2024/ac/a/d)